Hyperpolarized 13C-Pyruvate Imaging for Pancreatic Cysts
Trial Summary
What is the purpose of this trial?
To learn if Hyperpolarized C-Pyruvate Magnetic Resonance (HP-MR) Spectroscopic Imaging can help doctors detect low-risk (benign) and high-risk (malignant) cysts.
Research Team
Florencia McAllister, MD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for adults who are planning to have surgery or a biopsy on their pancreatic cysts. They must be able to understand and sign consent forms, regardless of language. It's not for those with certain implants, pregnant or breastfeeding women, women not using birth control, individuals over 260 lbs, those with heart rhythm problems, MRI contraindications, Gadavist contrast allergy, or cognitive impairments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Surgical Imaging
Participants undergo Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging prior to surgical resection
Surgical Resection
Participants undergo surgical resection or cyst wall biopsy to obtain tissue samples for further analysis
Follow-up
Participants are monitored for safety and effectiveness after surgical resection
Treatment Details
Interventions
- Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor